Policy AI & Digital Biotech & Health29 SEP 2026

China's AI pharma sector converges on policy, capital, and clinical milestone

Three simultaneous developments — a new Five-Year Plan, a $2.9 billion Series A record, and the world's first AI-designed drug entering Phase III — mark a structural shift in China's pharmaceutical industry. CITIC Securities assessed 2026 as the most commercially certain year yet for AI healthcare.

Subscriber Content

Subscribe to read the full analysis

From $9/month · 7-day free trial

Start Free Trial

Already a subscriber? Log in

Policy Energy & Cleantech29 September 2026

MIIT and six ministries release battery industry plan targeting solid-state scale-up by 2030

China's 15th Five-Year Plan for batteries sets 2030 as the target year for preliminary large-scale deployment of all-solid-state batteries, with leading manufacturers required to reach parts-per-billion defect rates.

Policy Mobility & EV Europe28 September 2026

EU presses UK to align tariffs on Chinese electric vehicles

Brussels is pushing London to match EU duties on Chinese-built battery electric vehicles, which can reach 45.3% in total. Chinese brands have reached approximately 15% of UK new vehicle registrations in H1 2026; across the first eight months of 2026, the five largest Chinese groups held 9.

Policy Energy & Cleantech Americas Asia Pacific+325 September 2026

China has cancelled two-thirds of its planned overseas coal power capacity

A joint report by CREA and PACS — both advocacy-oriented research organisations — finds that 61.5 gigawatts of Chinese-backed overseas coal capacity has been cancelled in the five years since Xi Jinping's 2021 UN pledge. The cancellations are projected to avoid 6.